Posts tagged NeuroTech
Cognixion Raises $12 Million to Enhance Assisted Reality (AR) Tech for Communication Disabilities

Funding round led by Prime Movers Lab, including Northwell Health, Amazon Alexa Fund and Volta Circle

SANTA BARBARA, Calif., Nov 16, 2021 /PRNewswire/ -- SANTA BARBARA, Calif., Nov 16, 2021 /PRNewswire/ -- Cognixion®, a neural interface startup, raised $12 million in seed funding to develop AI-powered neural interfaces that unlock speech and smart home controls for the hundreds of millions of people worldwide with communication and physical disabilities. The funding will help Cognixion develop new adaptive interfaces that make the Assisted Reality technology easier to use by everyone. Prime Movers Lab led the round with co-investors Northwell Health, Amazon Alexa Fund and Volta Circle.

 

Cognixion’s patented non-invasive, wireless brain-computer interface with an integrated augmented reality display, Cognixion ONE, detects the signals from the user's brainwaves associated with visual fixation on interactive objects and enables hands-free, voice-free control of AR/XR applications in the headset. Cognixion ONE is a closed-loop device that stimulates the visual cortex within the brain and reads its activity while sending control signals back to the AR application. It also integrates with leading research software.

 

In addition to Cognixion ONE, the company is building advanced machine learning algorithms and an AI-powered language system, which adapts to each user's unique communication style, making it more efficient at recognizing and anticipating what they intend to communicate. Equally exciting, a Cognixion headset user will be able to interface directly with Amazon Alexa from anywhere, accessing the smart assistant’s functions within the headset to interact with their environment and control smart devices, or access news, music, information and more.

 

“Cognixion is solving usability and accessibility issues for AR/XR and enabling new capabilities for people with disabilities today,” says Andreas Forsland, Cognixion Founder and CEO, “And in the near future, we see our innovations becoming a fundamental part of the metaverse, as a biological interface plus highly adaptive algorithms that unlock new use cases for XR.”

 

“We believe that technology should be inclusive and universally accessible to every individual, and everyone deserves a solution that can adapt to their needs – and that it’s possible to build ONE solution that can be personalized for communication, information access, interacting with smart devices, and everything else life has to offer,” Andreas Forsland said. “Prime Movers Lab has the same focus around making augmentative human capabilities a reality. Unlike most VCs, Prime Movers Lab is an extension of our team. In addition to the funding that they are providing, they are already helping us with hiring, marketing, government relations and building a pipeline of prospective customers.”

 

“Cognixion has created a breakthrough human-machine interface that accelerates and enriches human communication and connection,” Prime Movers Lab General Partner, Amy Kruse said. “You would think that Cognixion ONE is something out of science fiction if it didn’t already exist.  We believe that it will be a fundamentally life-changing and integral blend of an AI software platform with hardware to assist people of all ages who live with speech and motor disabilities, including Cerebral Palsy, Brainstem Stroke, ALS and many other conditions. Further we see the broader expansion of this platform to extend to all users to enrich life experiences, including: gaming, apps, the metaverse, and beyond. ”

 

“Cognixion ONE’s combination of visual stimulation and EEG reading could profoundly change the means of communication for patients with physical and neurological impairments,” said Dr. Souhel Najjar, SVP and Executive Director of the Neurology Service Line at Northwell Health. “We look forward to collaborating with the Cognixion team as they develop this technology and assess its efficacy in addressing this significant challenge.”

 

“Cognixion’s technology has the potential to revolutionize the way patients with impairments can communicate in a variety of settings. We believe Northwell’s investment and expertise will support Cognixion’s expansion into health care provider markets,” said Rich Mulry, President and CEO of Northwell Holdings & Ventures.

Click here to find more information about Cognixion ONE and to submit interest for pre-order.

If you’d like to work at Cognixion, click here to preview career opportunities.






About Cognixion

Cognixion is an internationally award-winning neuroscience and technology company pioneering the field of Assisted Reality.  Cognixion develops AI powered non-invasive BCI (Brain Computer Interface), assistive tech, and useful applications for people, including those affected by neurodevelopmental disorders and injuries to the brain and spinal cord. Based in Santa Barbara, California, the company develops software that helps people with communication challenges express themselves significantly faster than any other solution on the market, and provides a direct non-verbal interface to control Alexa enabled devices around the home, school and workplace.  For more information, please visit https://cognixion.com.




About Prime Movers Lab

Prime Movers Lab invests in breakthrough scientific startups founded by Prime Movers, the inventors who transform billions of lives. We invest in companies reinventing energy, transportation, infrastructure, manufacturing, agriculture and human augmentation. Portfolio investments span in-space transportation, industrial solar heat, ag tech, brain upgrades, nanostructured materials, wafer slicing, prosthetics, 3D printing, mobility, longevity and AI. For more information, please visit https://www.primemoverslab.com.




About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, 830 outpatient facilities and more than 16,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 77,000 employees – 18,900 nurses and 4,800 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Transformative Tech, NeuroTech, and Biohacking - Fundraising in 2020 and 2021

Video Presentation of the HealthTech, Biohacking and Transformative Technology Investment Market

A research report on the state of Transformative Tech investing in 2021 by Wesley King from Coherent Capital, followed by a panel with: - Alina Trigubenko: C...

Rune Labs $5M Seed - Closed Loop Data for Neuromodulation

University of Minnesota joins in academic partnership

Rune Labs, a software developer enabling the next wave of biofeedback in neuroscience therapeutics, announced a $5 million seed round led by DigiTx Partners. Other participating investors include TruVenturo, Moment Ventures, Loup Ventures and Sabbatical Ventures. Since the company’s founding in 2018, Rune Labs has raised a total of $7.3 million.

Rune Labs partners with leading medtech and pharmaceutical companies to label, organize, and analyze brain data. Rune Labs is focused on supporting neuromodulation therapies such as Deep Brain Stimulation (DBS) and Transcranial Magnetic Stimulation (TMS). Current device-based therapies generate a lot of data, including directly from brain signals. The mass of data is currently underutilized in trials and patient care as DBS and TMS manufacturers do not have a way to manage brain data at a large scale.

“Over the past two decades, we have witnessed tremendous improvements in neurostimulation devices for multiple neurologic conditions. What we are now seeing is the power of the information that could be derived from these devices. The technology Rune Labs is developing with neurologic and biometric data will optimize clinical care for many individuals with debilitating neurological and mental health conditions,” said David J. Kim, Managing Director, DigiTx Partners.

Using their platform, Rune Labs can sequence brain data both longitudinally for a single patient and across multiple patients, studies, and centers to be analyzed with machine learning tools. They are able to work with industry standard systems from Medtronic and Abbott as well as mobile health apps and devices… and they are and fully HIPAA compliant.

“This round of funding, following closely on last year’s, continues to validate our approach, technology and strategy,” said Brian Pepin, founder and CEO, Rune Labs. “Strong financial backing from credible partners and world-class academic collaborators continues to position us to help better understand the brain in order to improve neuromodulation therapies that can improve the quality of patients’ lives.”

The company will use the funds to continue to invest in R&D and to develop additional products.

About Rune Labs

Rune Labs, Inc. takes brain imaging and electrophysiology data generated in the course of clinical studies and patient care and makes this data useful for neuroscience therapeutics. We partner closely with med-tech and pharma companies to help develop and deliver precision therapies for Parkinson's disease, Epilepsy, Depression, Obsessive Compulsive Disorder, and other brain diseases. For more information visit www.runelabs.io.